Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
Earnings Scheduled For May 11, 2022
Companies Reporting Before The Bell
• Great Elm Capital (NASDAQ:GECC) is expected to report earnings for its first quarter.
Benzinga’s Daily Brief On Trending Tickers For April 12, 2022: Veru, Kohl’s Corporation, BioCardia, And More
Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the
Earnings Scheduled For March 28, 2022
Companies Reporting Before The Bell
• LGL Group (AMEX:LGL) is likely to report quarterly earnings at $0.10 per share on revenue of $7.20 million.
The Week Ahead In Biotech (March 27-April 2): Lipocine, Akebia, Merck Await FDA Verdicts, Adcom Test For Amylyx, BioNTech Earnings And More
Biotech stocks reversed course in the week ending March 25, as an increase in risk appetite prompted traders to move money out of defensives and into risky bets.
Cyclacel Pharmaceuticals’s Earnings: A Preview
Cyclacel Pharmaceuticals (NASDAQ:CYCC) is set to give its latest quarterly earnings report on Monday, 2022-03-28. Here's what investors need to know before the announcement.
Analysts estimate that Cyclacel Pharmaceuticals will report an earnings per share (EPS) of $-0.65.
12 Health Care Stocks Moving In Thursday’s After-Market Session
Gainers
NeuroOne Medical Tech (NASDAQ:NMTC) stock moved upwards by 6.47% to $2.63 during Thursday's after-market session. The company's market cap stands at $41.4 million.
Cyclacel Pharmaceuticals Q3 EPS $(0.54) Beats $(0.65) Estimate
Cyclacel Pharmaceuticals (NASDAQ:CYCC) reported quarterly losses of $(0.54) per share which beat the analyst consensus estimate of $(0.65) by 16.92 percent. This is a 14.89 percent decrease over losses of $(0.47) per